nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0988	0.178	CbGbCtD
Almotriptan—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0858	0.155	CbGbCtD
Almotriptan—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0715	0.129	CbGbCtD
Almotriptan—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0571	0.103	CbGbCtD
Almotriptan—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0483	0.0872	CbGbCtD
Almotriptan—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0374	0.0676	CbGbCtD
Almotriptan—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0361	0.0652	CbGbCtD
Almotriptan—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0348	0.0628	CbGbCtD
Almotriptan—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.028	0.0504	CbGbCtD
Almotriptan—HTR1D—meninx—peripheral nervous system neoplasm	0.0258	0.186	CbGeAlD
Almotriptan—HTR1B—dura mater—peripheral nervous system neoplasm	0.0246	0.177	CbGeAlD
Almotriptan—HTR1D—dura mater—peripheral nervous system neoplasm	0.0238	0.171	CbGeAlD
Almotriptan—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.016	0.0288	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0157	0.0283	CbGbCtD
Almotriptan—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0146	0.0264	CbGbCtD
Almotriptan—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0106	0.076	CbGeAlD
Almotriptan—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.0102	0.0736	CbGeAlD
Almotriptan—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00999	0.018	CbGbCtD
Almotriptan—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00752	0.0542	CbGeAlD
Almotriptan—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00728	0.0524	CbGeAlD
Almotriptan—HTR1B—ganglion—peripheral nervous system neoplasm	0.00381	0.0274	CbGeAlD
Almotriptan—HTR1D—ganglion—peripheral nervous system neoplasm	0.00369	0.0265	CbGeAlD
Almotriptan—FMO3—parotid gland—peripheral nervous system neoplasm	0.00301	0.0216	CbGeAlD
Almotriptan—MAOA—nerve—peripheral nervous system neoplasm	0.00284	0.0205	CbGeAlD
Almotriptan—MAOA—ganglion—peripheral nervous system neoplasm	0.00281	0.0202	CbGeAlD
Almotriptan—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00187	0.0135	CbGeAlD
Almotriptan—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00181	0.013	CbGeAlD
Almotriptan—HTR1B—brainstem—peripheral nervous system neoplasm	0.00166	0.0119	CbGeAlD
Almotriptan—HTR1D—brainstem—peripheral nervous system neoplasm	0.0016	0.0115	CbGeAlD
Almotriptan—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.00138	0.00993	CbGeAlD
Almotriptan—MAOA—parotid gland—peripheral nervous system neoplasm	0.0013	0.00936	CbGeAlD
Almotriptan—MAOA—brainstem—peripheral nervous system neoplasm	0.00122	0.00879	CbGeAlD
Almotriptan—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000725	0.00522	CbGeAlD
Almotriptan—MAOA—cerebellum—peripheral nervous system neoplasm	0.000602	0.00433	CbGeAlD
Almotriptan—Sumatriptan—ABCB1—peripheral nervous system neoplasm	0.000478	0.553	CrCbGaD
Almotriptan—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000452	0.00325	CbGeAlD
Almotriptan—Eletriptan—ABCB1—peripheral nervous system neoplasm	0.000387	0.447	CrCbGaD
Almotriptan—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000358	0.00257	CbGeAlD
Almotriptan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00032	0.00104	CcSEcCtD
Almotriptan—Rash—Topotecan—peripheral nervous system neoplasm	0.00032	0.00104	CcSEcCtD
Almotriptan—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000319	0.00104	CcSEcCtD
Almotriptan—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000318	0.00104	CcSEcCtD
Almotriptan—Headache—Topotecan—peripheral nervous system neoplasm	0.000317	0.00104	CcSEcCtD
Almotriptan—Rash—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00104	CcSEcCtD
Almotriptan—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00104	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000317	0.00104	CcSEcCtD
Almotriptan—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000317	0.00103	CcSEcCtD
Almotriptan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00103	CcSEcCtD
Almotriptan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00103	CcSEcCtD
Almotriptan—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000316	0.00103	CcSEcCtD
Almotriptan—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000316	0.00103	CcSEcCtD
Almotriptan—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000315	0.00103	CcSEcCtD
Almotriptan—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000315	0.00103	CcSEcCtD
Almotriptan—Headache—Tretinoin—peripheral nervous system neoplasm	0.000315	0.00103	CcSEcCtD
Almotriptan—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.00103	CcSEcCtD
Almotriptan—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000315	0.00103	CcSEcCtD
Almotriptan—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.00103	CcSEcCtD
Almotriptan—Pain—Vincristine—peripheral nervous system neoplasm	0.000314	0.00103	CcSEcCtD
Almotriptan—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.00103	CcSEcCtD
Almotriptan—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.00103	CcSEcCtD
Almotriptan—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000314	0.00103	CcSEcCtD
Almotriptan—Rash—Melphalan—peripheral nervous system neoplasm	0.000313	0.00102	CcSEcCtD
Almotriptan—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000313	0.00102	CcSEcCtD
Almotriptan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00102	CcSEcCtD
Almotriptan—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00031	0.00101	CcSEcCtD
Almotriptan—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00101	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000308	0.00101	CcSEcCtD
Almotriptan—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000306	0.001	CcSEcCtD
Almotriptan—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000306	0.001	CcSEcCtD
Almotriptan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000303	0.000989	CcSEcCtD
Almotriptan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.000984	CcSEcCtD
Almotriptan—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.000984	CcSEcCtD
Almotriptan—Nausea—Topotecan—peripheral nervous system neoplasm	0.000301	0.000983	CcSEcCtD
Almotriptan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.0003	0.000981	CcSEcCtD
Almotriptan—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000981	CcSEcCtD
Almotriptan—Confusional state—Etoposide—peripheral nervous system neoplasm	0.0003	0.00098	CcSEcCtD
Almotriptan—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000977	CcSEcCtD
Almotriptan—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000299	0.000975	CcSEcCtD
Almotriptan—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000299	0.000975	CcSEcCtD
Almotriptan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000297	0.000971	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000296	0.000966	CcSEcCtD
Almotriptan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000295	0.000963	CcSEcCtD
Almotriptan—Nausea—Melphalan—peripheral nervous system neoplasm	0.000295	0.000963	CcSEcCtD
Almotriptan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000291	0.000952	CcSEcCtD
Almotriptan—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00029	0.000948	CcSEcCtD
Almotriptan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00029	0.000948	CcSEcCtD
Almotriptan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00029	0.000948	CcSEcCtD
Almotriptan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000289	0.000945	CcSEcCtD
Almotriptan—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000289	0.000944	CcSEcCtD
Almotriptan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000287	0.000939	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000936	CcSEcCtD
Almotriptan—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000933	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000926	CcSEcCtD
Almotriptan—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000921	CcSEcCtD
Almotriptan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000281	0.000918	CcSEcCtD
Almotriptan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.000917	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000916	CcSEcCtD
Almotriptan—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000907	CcSEcCtD
Almotriptan—Pain—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000907	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000904	CcSEcCtD
Almotriptan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.000893	CcSEcCtD
Almotriptan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00027	0.000884	CcSEcCtD
Almotriptan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.000881	CcSEcCtD
Almotriptan—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000874	CcSEcCtD
Almotriptan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000874	CcSEcCtD
Almotriptan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000267	0.000872	CcSEcCtD
Almotriptan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000265	0.000866	CcSEcCtD
Almotriptan—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000864	CcSEcCtD
Almotriptan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000264	0.000864	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000863	CcSEcCtD
Almotriptan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000263	0.00086	CcSEcCtD
Almotriptan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000261	0.000853	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000852	CcSEcCtD
Almotriptan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.000852	CcSEcCtD
Almotriptan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.000846	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000257	0.000839	CcSEcCtD
Almotriptan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000838	CcSEcCtD
Almotriptan—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000256	0.000838	CcSEcCtD
Almotriptan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000837	CcSEcCtD
Almotriptan—Pain—Etoposide—peripheral nervous system neoplasm	0.000254	0.000831	CcSEcCtD
Almotriptan—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00083	CcSEcCtD
Almotriptan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000252	0.000823	CcSEcCtD
Almotriptan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000251	0.000821	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000809	CcSEcCtD
Almotriptan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000805	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000801	CcSEcCtD
Almotriptan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000245	0.000801	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000799	CcSEcCtD
Almotriptan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000244	0.000797	CcSEcCtD
Almotriptan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000243	0.000794	CcSEcCtD
Almotriptan—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000243	0.000793	CcSEcCtD
Almotriptan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.000791	CcSEcCtD
Almotriptan—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.000785	CcSEcCtD
Almotriptan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.000784	CcSEcCtD
Almotriptan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000781	CcSEcCtD
Almotriptan—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00078	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000774	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000768	CcSEcCtD
Almotriptan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000235	0.000768	CcSEcCtD
Almotriptan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000235	0.000768	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000768	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000763	CcSEcCtD
Almotriptan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000233	0.000763	CcSEcCtD
Almotriptan—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000761	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000761	CcSEcCtD
Almotriptan—Rash—Vincristine—peripheral nervous system neoplasm	0.000231	0.000756	CcSEcCtD
Almotriptan—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000231	0.000755	CcSEcCtD
Almotriptan—Headache—Vincristine—peripheral nervous system neoplasm	0.00023	0.000751	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000745	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000741	CcSEcCtD
Almotriptan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.000739	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000739	CcSEcCtD
Almotriptan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000726	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000716	CcSEcCtD
Almotriptan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000219	0.000716	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000715	CcSEcCtD
Almotriptan—Nausea—Vincristine—peripheral nervous system neoplasm	0.000218	0.000712	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000711	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000711	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000706	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000704	CcSEcCtD
Almotriptan—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000213	0.000697	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000692	CcSEcCtD
Almotriptan—Chills—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000688	CcSEcCtD
Almotriptan—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00021	0.000687	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000683	CcSEcCtD
Almotriptan—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000206	0.000674	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000672	CcSEcCtD
Almotriptan—Rash—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000669	CcSEcCtD
Almotriptan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000668	CcSEcCtD
Almotriptan—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000667	CcSEcCtD
Almotriptan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000203	0.000665	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000663	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000661	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000658	CcSEcCtD
Almotriptan—Tension—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000655	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000653	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000648	CcSEcCtD
Almotriptan—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000645	CcSEcCtD
Almotriptan—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000197	0.000642	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000641	CcSEcCtD
Almotriptan—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000636	CcSEcCtD
Almotriptan—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000193	0.00063	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000629	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000621	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000619	CcSEcCtD
Almotriptan—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000189	0.000618	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000617	CcSEcCtD
Almotriptan—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000613	CcSEcCtD
Almotriptan—Rash—Etoposide—peripheral nervous system neoplasm	0.000187	0.000613	CcSEcCtD
Almotriptan—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000187	0.000612	CcSEcCtD
Almotriptan—Headache—Etoposide—peripheral nervous system neoplasm	0.000186	0.000609	CcSEcCtD
Almotriptan—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000606	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000605	CcSEcCtD
Almotriptan—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000602	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.0006	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000599	CcSEcCtD
Almotriptan—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000598	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000597	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00059	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000586	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000582	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000578	CcSEcCtD
Almotriptan—Nausea—Etoposide—peripheral nervous system neoplasm	0.000177	0.000577	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000576	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000573	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000568	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000568	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000568	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000567	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000566	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000564	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000561	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000557	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000556	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000555	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000554	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000549	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000546	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000545	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000543	CcSEcCtD
Almotriptan—Shock—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000536	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000535	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000534	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000533	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000531	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000529	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000526	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000526	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000526	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000526	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000524	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000522	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000519	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000514	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000508	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000504	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000496	CcSEcCtD
Almotriptan—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000496	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000494	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000493	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000492	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000489	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000489	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000487	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000486	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000484	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000479	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00047	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00047	CcSEcCtD
Almotriptan—Pain—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000466	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000459	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000456	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000452	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000449	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000449	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000448	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000445	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000444	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000435	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000434	CcSEcCtD
Almotriptan—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000431	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00043	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00043	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000415	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000412	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000401	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000398	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000398	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000391	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000385	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000373	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000371	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000362	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00036	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000356	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000346	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000345	CcSEcCtD
Almotriptan—Rash—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000343	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000343	CcSEcCtD
Almotriptan—Headache—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000341	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000333	CcSEcCtD
Almotriptan—Nausea—Epirubicin—peripheral nervous system neoplasm	9.9e-05	0.000323	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.00032	CcSEcCtD
Almotriptan—Rash—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000318	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000317	CcSEcCtD
Almotriptan—Headache—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000316	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000299	CcSEcCtD
